WVE logo

Wave Life Sciences Ltd. (WVE) Cash from operations

annual CFO:

-$151.03M-$131.59M(-677.24%)
December 31, 2024

Summary

  • As of today (July 6, 2025), WVE annual cash flow from operations is -$151.03 million, with the most recent change of -$131.59 million (-677.24%) on December 31, 2024.
  • During the last 3 years, WVE annual CFO has fallen by -$62.03 million (-69.71%).
  • WVE annual CFO is now -4153.06% below its all-time high of -$3.55 million, reached on December 31, 2013.

Performance

WVE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

quarterly CFO:

-$63.04M-$19.39M(-44.43%)
March 31, 2025

Summary

  • As of today (July 6, 2025), WVE quarterly cash flow from operations is -$63.04 million, with the most recent change of -$19.39 million (-44.43%) on March 31, 2025.
  • Over the past year, WVE quarterly CFO has dropped by -$29.61 million (-88.56%).
  • WVE quarterly CFO is now -173.71% below its all-time high of $85.52 million, reached on March 31, 2023.

Performance

WVE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

TTM CFO:

-$180.63M-$29.61M(-19.60%)
March 31, 2025

Summary

  • As of today (July 6, 2025), WVE TTM cash flow from operations is -$180.63 million, with the most recent change of -$29.61 million (-19.60%) on March 31, 2025.
  • Over the past year, WVE TTM CFO has dropped by -$42.25 million (-30.53%).
  • WVE TTM CFO is now -11057.07% below its all-time high of -$1.62 million, reached on March 31, 2015.

Performance

WVE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WVE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-677.2%-88.6%-30.5%
3 y3 years-69.7%-58.1%-113.8%
5 y5 years+19.8%-140.2%-6.7%

WVE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-677.2%at low-173.7%at low-7470.5%at low
5 y5-year-677.2%+19.8%-173.7%at low-7470.5%at low
alltimeall time-4153.1%+19.8%-173.7%at low<-9999.0%+4.0%

WVE Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$63.04M(+44.4%)
-$180.63M(+19.6%)
Dec 2024
-$151.03M(+677.2%)
-$43.65M(-6.1%)
-$151.03M(+7.4%)
Sep 2024
-
-$46.48M(+69.2%)
-$140.62M(+9.3%)
Jun 2024
-
-$27.47M(-17.8%)
-$128.60M(-7.1%)
Mar 2024
-
-$33.43M(+0.6%)
-$138.38M(+612.2%)
Dec 2023
-$19.43M(-84.8%)
-$33.24M(-3.5%)
-$19.43M(-1.0%)
Sep 2023
-
-$34.46M(-7.5%)
-$19.63M(+81.4%)
Jun 2023
-
-$37.26M(-143.6%)
-$10.82M(+353.5%)
Mar 2023
-
$85.52M(-355.7%)
-$2.39M(-98.1%)
Dec 2022
-$127.78M(+43.6%)
-$33.44M(+30.4%)
-$127.78M(+26.0%)
Sep 2022
-
-$25.65M(-11.0%)
-$101.37M(-2.4%)
Jun 2022
-
-$28.82M(-27.7%)
-$103.91M(+23.0%)
Mar 2022
-
-$39.87M(+466.9%)
-$84.49M(-5.1%)
Dec 2021
-$88.99M(-23.3%)
-$7.03M(-75.0%)
-$88.99M(-21.5%)
Sep 2021
-
-$28.18M(+199.8%)
-$113.38M(+7.6%)
Jun 2021
-
-$9.40M(-78.8%)
-$105.36M(-21.4%)
Mar 2021
-
-$44.38M(+41.3%)
-$134.11M(+15.6%)
Dec 2020
-$115.98M(-38.4%)
-$31.41M(+55.7%)
-$115.98M(-20.5%)
Sep 2020
-
-$20.17M(-47.1%)
-$145.81M(-13.9%)
Jun 2020
-
-$38.15M(+45.3%)
-$169.32M(+3.2%)
Mar 2020
-
-$26.25M(-57.1%)
-$164.10M(-12.8%)
DateAnnualQuarterlyTTM
Dec 2019
-$188.23M(+723.3%)
-$61.24M(+40.2%)
-$188.23M(+17.8%)
Sep 2019
-
-$43.68M(+32.7%)
-$159.81M(+10.1%)
Jun 2019
-
-$32.93M(-34.6%)
-$145.14M(+255.6%)
Mar 2019
-
-$50.38M(+53.5%)
-$40.82M(+78.5%)
Dec 2018
-$22.86M(-72.7%)
-$32.82M(+13.1%)
-$22.86M(+78.7%)
Sep 2018
-
-$29.01M(-140.6%)
-$12.80M(+77.8%)
Jun 2018
-
$71.39M(-320.2%)
-$7.20M(-92.7%)
Mar 2018
-
-$32.43M(+42.5%)
-$98.68M(+17.9%)
Dec 2017
-$83.67M(+162.1%)
-$22.75M(-2.8%)
-$83.67M(+12.7%)
Sep 2017
-
-$23.41M(+16.5%)
-$74.26M(+18.5%)
Jun 2017
-
-$20.09M(+15.3%)
-$62.69M(+48.5%)
Mar 2017
-
-$17.42M(+30.5%)
-$42.21M(+32.2%)
Dec 2016
-$31.93M(+154.8%)
-$13.35M(+12.8%)
-$31.93M(+26.5%)
Sep 2016
-
-$11.83M(-3133.8%)
-$25.25M(+55.2%)
Jun 2016
-
$390.00K(-105.5%)
-$16.26M(-9.9%)
Mar 2016
-
-$7.14M(+7.0%)
-$18.04M(+44.0%)
Dec 2015
-$12.53M(+183.0%)
-$6.67M(+134.1%)
-$12.53M(+113.8%)
Sep 2015
-
-$2.85M(+104.6%)
-$5.86M(+94.6%)
Jun 2015
-
-$1.39M(-14.0%)
-$3.01M(+86.0%)
Mar 2015
-
-$1.62M
-$1.62M
Dec 2014
-$4.43M(+24.6%)
-
-
Dec 2013
-$3.55M
-
-

FAQ

  • What is Wave Life Sciences Ltd. annual cash flow from operations?
  • What is the all time high annual CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. annual CFO year-on-year change?
  • What is Wave Life Sciences Ltd. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. quarterly CFO year-on-year change?
  • What is Wave Life Sciences Ltd. TTM cash flow from operations?
  • What is the all time high TTM CFO for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. TTM CFO year-on-year change?

What is Wave Life Sciences Ltd. annual cash flow from operations?

The current annual CFO of WVE is -$151.03M

What is the all time high annual CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high annual cash flow from operations is -$3.55M

What is Wave Life Sciences Ltd. annual CFO year-on-year change?

Over the past year, WVE annual cash flow from operations has changed by -$131.59M (-677.24%)

What is Wave Life Sciences Ltd. quarterly cash flow from operations?

The current quarterly CFO of WVE is -$63.04M

What is the all time high quarterly CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high quarterly cash flow from operations is $85.52M

What is Wave Life Sciences Ltd. quarterly CFO year-on-year change?

Over the past year, WVE quarterly cash flow from operations has changed by -$29.61M (-88.56%)

What is Wave Life Sciences Ltd. TTM cash flow from operations?

The current TTM CFO of WVE is -$180.63M

What is the all time high TTM CFO for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high TTM cash flow from operations is -$1.62M

What is Wave Life Sciences Ltd. TTM CFO year-on-year change?

Over the past year, WVE TTM cash flow from operations has changed by -$42.25M (-30.53%)
On this page